Related Experiment Videos
The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development
Robyn N McKeller1, Jennifer L Fowler, Justine J Cunningham
1Department of Hematology/Oncology, Developmental Neurobiology, St. Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, USA.
Abstract:
A key tumor suppressor mechanism that is disrupted frequently in human cancer involves the ARF and p53 genes. In mouse fibroblasts, the Arf gene product responds to abnormal mitogenic signals to activate p53 and trigger either cell cycle arrest or apoptosis. Recent evidence indicates that Arf also has p53-independent functions that may contribute to its tumor suppressor activity. Using Arf(-/-) and p53(-/-) mice, we have discovered a p53-independent requirement for Arf in the developmental regression of the hyaloid vascular system (HVS) in the mouse eye. Arf is expressed in the vitreous of the eye and is induced before HVS regression in the first postnatal week. In the absence of Arf, failed HVS regression causes a pathological process that resembles persistent hyperplastic primary vitreous, a developmental human eye disease thought to have a genetic basis. These findings demonstrate an essential and unexpected role for Arf during mouse eye development, provide insights into the potential genetic basis for persistent hyperplastic primary vitreous, and indicate that Arf regulates vascular regression in a p53-independent manner. The latter finding raises the possibility that Arf may function as a tumor suppressor at least in part by regulating tumor angiogenesis.
Insights
The ARF gene is essential for eye development in mice, regulating the regression of the hyaloid vascular system independently of p53. This discovery sheds light on persistent hyperplastic primary vitreous and ARF
Area of Science:
- Oncology
- Developmental Biology
- Ophthalmology
Background:
- The ARF and p53 genes are crucial tumor suppressors frequently disrupted in human cancers.
- ARF typically activates p53 in response to aberrant mitogenic signals, inducing cell cycle arrest or apoptosis.
- Emerging evidence suggests ARF possesses p53-independent functions relevant to tumor suppression.
Purpose of the Study:
- To investigate the role of ARF in eye development, specifically the regression of the hyaloid vascular system (HVS).
- To determine if ARF's function in HVS regression is dependent on p53.
- To explore the potential link between ARF, HVS regression, and human eye diseases like persistent hyperplastic primary vitreous.
Main Methods:
- Utilized Arf(-/-) and p53(-/-) knockout mice models.
- Analyzed ARF expression patterns in the developing mouse eye vitreous.
- Observed HVS development and regression in the first postnatal week in genetically modified mice.
Main Results:
- Discovered a p53-independent requirement for ARF in the developmental regression of the hyaloid vascular system (HVS).
- ARF is expressed in the eye vitreous and its induction precedes HVS regression.
- Absence of ARF leads to failed HVS regression, mimicking persistent hyperplastic primary vitreous.
Conclusions:
- ARF plays an essential and previously unrecognized role in mouse eye development and HVS regression.
- ARF's p53-independent regulation of vascular regression suggests a role in controlling tumor angiogenesis.
- Findings provide insights into the genetic basis of persistent hyperplastic primary vitreous and ARF's broader tumor suppressor functions.